AbbVie expands Oxford R&D facility as part of £120 million-plus investment
Open the sourceReported by Investing.com, investing.com, 4 November 2026, by Reuters
45Impact 45 of 100, routine
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Muhabbit only has the headline for this one. The full report is at investing.com.
Named in this story
AbbVie, Oxford